David R. Wells - Jul 9, 2025 Form 4 Insider Report for HeartSciences Inc. (HSCS)

Role
Director
Signature
/s/ David R. Wells
Stock symbol
HSCS
Transactions as of
Jul 9, 2025
Transactions value $
$0
Form type
4
Date filed
7/11/2025, 09:00 PM
Previous filing
Jan 21, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Wells David R. Director C/O HEARTSCIENCES INC.,, 550 RESERVE STREET, SUITE 360, SOUTHLAKE /s/ David R. Wells 2025-07-11 0001480371

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HSCS Stock Option (Right to Buy) Award +25K 25K Jul 9, 2025 Common Stock 25K $4.37 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These options were granted to the Reporting Person effective as of July 9, 2025 (the "Effective Date"), pursuant to the approval of the compensation committee of the Issuer's board of directors.
F2 The options shall vest and be exercisable as follows: one-fourth of the options vested on the Effective Date and the remainder of the options shall vest in equal increments thereafter on each successive three-month anniversary of the Effective Date, subject to the Reporting Person's continued service on the Board through each applicable vesting date and subject to the terms of the Issuer's 2023 Equity Incentive Plan, as amended (the "2023 Plan").
F3 These options expire ten years from the Effective Date, unless terminated sooner in accordance with the Issuer's 2023 Plan or the underlying options grant agreement.